Cambridge Health Alliance, Cambridge, Massachusetts.
Harvard Medical School, Boston, Massachusetts.
JAMA Intern Med. 2021 Jul 1;181(7):968-976. doi: 10.1001/jamainternmed.2021.2441.
Air quality has improved and smoking rates have declined over the past half-century in the US. It is unknown whether such secular improvements, and other policies, have helped close socioeconomic gaps in respiratory health.
To describe long-term trends in socioeconomic disparities in respiratory disease prevalence, pulmonary symptoms, and pulmonary function.
DESIGN, SETTING, AND PARTICIPANTS: This repeated cross-sectional analysis of the nationally representative National Health and Nutrition Examination Surveys (NHANES) and predecessor surveys, conducted from 1959 to 2018. included 160 495 participants aged 6 to 74 years.
Family income quintile defined using year-specific thresholds; educational attainment.
Trends in socioeconomic disparities in prevalence of current/former smoking among adults aged 25 to 74 years; 3 respiratory symptoms (dyspnea on exertion, cough, and wheezing) among adults aged 40 to 74 years; asthma stratified by age (6-11, 12-17, and 18-74 years); chronic obstructive pulmonary disease ([COPD] adults aged 40-74 years); and 3 measures of pulmonary function (forced expiratory volume in 1 second [FEV1], forced vital capacity [FVC], and FEV1/FVC<0.70) among adults aged 24 to 74 years.
Our sample included 160 495 individuals surveyed between 1959 and 2018: 27 948 children aged 6 to 11 years; 26 956 children aged 12 to 17 years; and 105 591 adults aged 18 to 74 years. Income- and education-based disparities in smoking prevalence widened from 1971 to 2018. Socioeconomic disparities in respiratory symptoms persisted or worsened from 1959 to 2018. For instance, from 1971 to 1975, 44.5% of those in the lowest income quintile reported dyspnea on exertion vs 26.4% of those in the highest quintile, whereas from 2017 to 2018 the corresponding proportions were 48.3% and 27.9%. Disparities in cough and wheezing rose over time. Asthma prevalence rose for all children after 1980, but more sharply among poorer children. Income-based disparities in diagnosed COPD also widened over time, from 4.5 percentage points (age- and sex-adjusted) in 1971 to 11.3 percentage points from 2013 to 2018. Socioeconomic disparities in FEV1 and FVC also increased. For instance, from 1971 to 1975, the age- and height-adjusted FEV1 of men in the lowest income quintile was 203.6 mL lower than men in the highest quintile, a difference that widened to 248.5 mL from 2007 to 2012 (95% CI, -328.0 to -169.0). However, disparities in rates of FEV1/FVC lower than 0.70 changed little.
Socioeconomic disparities in pulmonary health persisted and potentially worsened over the past 6 decades, suggesting that the benefits of improved air quality and smoking reductions have not been equally distributed. Socioeconomic position may function as an independent determinant of pulmonary health.
在美国,过去半个世纪以来,空气质量得到了改善,吸烟率也有所下降。目前尚不清楚这些长期的改善以及其他政策是否有助于缩小呼吸系统健康方面的社会经济差距。
描述呼吸系统疾病患病率、肺部症状和肺功能方面的社会经济差异的长期趋势。
设计、地点和参与者:本研究为全国代表性的国家健康和营养检查调查(NHANES)及其前身调查的重复横断面分析,从 1959 年至 2018 年进行,共纳入 160495 名年龄在 6 至 74 岁的参与者。
使用特定年份的阈值定义家庭收入五分位数;教育程度。
25 至 74 岁成年人中当前/既往吸烟率的社会经济差异趋势;40 至 74 岁成年人中 3 种肺部症状(运动时呼吸困难、咳嗽和喘息);按年龄分层的哮喘(6-11、12-17 和 18-74 岁);慢性阻塞性肺疾病([COPD]40-74 岁成年人);24 至 74 岁成年人中 3 项肺功能指标(1 秒用力呼气量[FEV1]、用力肺活量[FVC]和 FEV1/FVC<0.70)。
我们的样本包括 1959 年至 2018 年期间接受调查的 160495 人:6 至 11 岁儿童 27948 人;12 至 17 岁儿童 26956 人;18 至 74 岁成年人 105591 人。从 1971 年到 2018 年,基于收入和教育的吸烟率差异扩大。从 1959 年到 2018 年,呼吸系统症状的社会经济差异持续存在或恶化。例如,1971 年至 1975 年,最低收入五分位数中报告呼吸困难的比例为 44.5%,而最高五分位数中报告呼吸困难的比例为 26.4%,而 2017 年至 2018 年,相应的比例分别为 48.3%和 27.9%。咳嗽和喘息的差异随着时间的推移而上升。自 1980 年以来,所有儿童的哮喘患病率均有所上升,但贫困儿童的上升幅度更大。基于收入的 COPD 诊断差异也随着时间的推移而扩大,从 1971 年的 4.5 个百分点(年龄和性别调整)增加到 2013 年至 2018 年的 11.3 个百分点。FEV1 和 FVC 的社会经济差异也有所增加。例如,从 1971 年到 1975 年,最低收入五分位数男性的年龄和身高调整后的 FEV1 比最高五分位数男性低 203.6 毫升,这一差距从 2007 年至 2012 年扩大到 248.5 毫升(95%CI,-328.0 至-169.0)。然而,FEV1/FVC 低于 0.70 的比率差异变化不大。
过去 60 年来,呼吸系统健康方面的社会经济差异持续存在,且可能恶化,这表明空气质量改善和吸烟减少带来的好处没有得到公平分配。社会经济地位可能是肺部健康的一个独立决定因素。